US FDA approves Eli Lilly’s advanced breast cancer drug combo
Eli Lilly said the US FDA has approved its drug combination to treat adults with advanced breast cancer that has spread to other parts of the body.
The US FDA has approved Eli Lilly's NYSE:LLY drug combination to treat adults with a type of advanced breast cancer that has spread to other parts of the body, the drugmaker said on Friday.Here are some details